The diagnosis of TAM requires a GATA1 mutation as well as an increase in blasts and/or certain clinical features (especially hepatosplenomegaly) in neonate with Down syndrome and may also be mosaic [14]. This evidence concerns the gene GATA1 and transient myeloproliferative syndrome.